Factors Associated with Increased Morbidity and Mortality of Obese and Overweight COVID-19 Patients

Abstract

Overweight and obesity are defined as an unnecessary accumulation of fat, which poses a risk to health. It is a well-identified risk factor for increased mortality due to heightened rates of heart disease, certain cancers, musculoskeletal disorders, and bacterial, protozoan and viral infections. The increasing prevalence of obesity is of concern, as conventional pathogenesis may indeed be increased in obese hosts rather than healthy hosts, especially during this COVID-19 pandemic. COVID-19 is a new disease and we do not have the luxury of cumulative data. Obesity activates the development of gene induced hypoxia and adipogenesis in obese animals. Several factors can influence obesity, for example, stress can increase the body weight by allowing people to consume high amounts of food with a higher propensity to consume palatable food. Obesity is a risk factor for the development of immune-mediated and some inflammatory-mediated diseases, including atherosclerosis and psoriasis, leading to a dampened immune response to infectious agents, leading to weaker post-infection impacts. Moreover, the obese host creates a special microenvironment for disease pathogenesis, marked by persistent low-grade inflammation. Therefore, it is advisable to sustain healthy eating habits by increasing the consumption of various plant-based and low-fat foods to protect our bodies and decrease the risk of infectious diseases, especially COVID-19.

The COVID-19 Pandemic Lockdowns and Changes in Body Weight among Polish Women. A Cross-Sectional Online Survey PLifeCOVID-19 Study

“…Specifically, obesity is a medical disorder with inflammation that induce immune response dysregulation. Regrettably, obese and overweight adults are also at higher risk of health decline with COVID-19 and need intensive care more often [57].…”

Impact of Diabetes in Patients Diagnosed With COVID-19

“…This exceptional obesogenic state may partly explain the presence of antiviral-resistance and vaccine-escape deviations in the obese population (19,20). Moreover, B-and Tcell responses are weakened in obese patients and even more so in obese patients with diabetes (21). After analyzing a case cohort of 70,000 individuals infected with COVID-19, the Chinese Centre for Disease Control and Prevention reported augmented mortality in individuals with diabetes, increasing from 2.3% in the general population to 7.3% in people with diabetes (22).…”

Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems

“…Diarrhoea, nausea and vomiting have been also reported [ 73 , 77 ]. The severe COVID-19 patients suffer from acute respiratory distress syndrome (ARDS), respiratory failure and may suffer from failure of other organs, requiring intensive care [ 52 , 70 , 78 ]. Because we are still in the midst of COVID-19 pandemic, it is too early to estimate the mortality rate compared to the previous SARS-CoV and MERS-CoV outbreaks, which were associated with 10% and 35% mortality, respectively [ 9 , 10 ].…”